Biohaven Ltd
Research Biohaven Ltd (BHVN) on Bullrun: market cap USD 2.17B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBHVN
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.17B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 130.53M
- Free cash flow-USD 149.92M
Valuation Snapshot
latest market cap is USD 2.17B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 738.82M | -USD 610.15M | n/a | -6.86 | USD 229.96M | USD 284.61M | USD 52.07M |
| FY2024 | USD 0 | -USD 846.42M | -USD 586.50M | n/a | -9.28 | USD 99.13M | USD 36.58M | USD 423.44M |
| FY2023 | n/a | -USD 408.17M | -USD 334.77M | n/a | -5.73 | USD 248.40M | USD 30.88M | USD 427.98M |
| FY2022 | n/a | -USD 570.28M | -USD 303.76M | n/a | -12.75 | USD 204.88M | n/a | USD 538.77M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.17B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.50B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.78B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.43B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 946.07M | n/a | n/a | n/a |
About Biohaven Ltd
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biohaven Ltd's market cap?
Biohaven Ltd's market capitalization is USD 2.17B.
What does Biohaven Ltd do?
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide.